A RNAseq was performed comparing 6 CML patients with high BCR::ABL1 expression with 6 healthy control individuals, comprising the investigation cohort to investigate these molecules. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.